| The phenotype of infiltrating macrophages influences arteriosclerotic plaque vulnerability in the carotid artery KY Cho, H Miyoshi, S Kuroda, H Yasuda, K Kamiyama, J Nakagawara, ... Journal of stroke and cerebrovascular diseases 22 (7), 910-918, 2013 | 204 | 2013 |
| HLA-DQB1* 03: 01 as a biomarker for genetic susceptibility to bullous pemphigoid induced by DPP-4 inhibitors H Ujiie, K Muramatsu, T Mushiroda, T Ozeki, H Miyoshi, H Iwata, ... The Journal of investigative dermatology 138 (5), 1201-1204, 2018 | 119 | 2018 |
| Hyponatremia can be a powerful predictor of the development of isolated ACTH deficiency associated with nivolumab treatment KY Cho, H Miyoshi, A Nakamura, T Kurita, T Atsumi Endocrine Journal 64 (2), 235-236, 2017 | 44 | 2017 |
| Improvement in treatment satisfaction after switching from liraglutide to dulaglutide in patients with type 2 diabetes: a randomized controlled trial T Takase, A Nakamura, C Yamamoto, H Nomoto, A Miya, M Dannoura, ... Journal of Diabetes Investigation 10 (3), 699-705, 2019 | 42 | 2019 |
| Ovarian morphology and prevalence of polycystic ovary syndrome in Japanese women with type 1 diabetes mellitus A Miyoshi, S Nagai, M Takeda, T Kondo, H Nomoto, H Kameda, A Hirai, ... Journal of diabetes investigation 4 (3), 326-329, 2013 | 34 | 2013 |
| Effects of dapagliflozin and/or insulin glargine on beta cell mass and hepatic steatosis in db/db mice K Omori, A Nakamura, H Miyoshi, K Takahashi, N Kitao, H Nomoto, ... Metabolism 98, 27-36, 2019 | 33 | 2019 |
| Favorable effect of sodium–glucose cotransporter 2 inhibitor, dapagliflozin, on non‐alcoholic fatty liver disease compared with pioglitazone KY Cho, A Nakamura, K Omori, T Takase, A Miya, K Yamamoto, ... Journal of Diabetes Investigation 12 (7), 1272-1277, 2021 | 32 | 2021 |
| Isolated adrenocorticotropic hormone deficiency associated with nivolumab therapy A Narahira, T Yanagi, KY Cho, A Nakamura, H Miyoshi, H Hata, K Imafuku, ... The Journal of Dermatology 44 (4), e70-e70, 2017 | 30 | 2017 |
| Satisfaction of switching to combination therapy with lixisenatide and basal insulin in patients with type 2 diabetes receiving multiple daily insulin injection therapy: a … A Miya, A Nakamura, H Miyoshi, KY Cho, S Nagai, Y Kurihara, S Aoki, ... Journal of diabetes investigation 9 (1), 119-126, 2018 | 29 | 2018 |
| Effect of the sodium–glucose cotransporter 2 inhibitor luseogliflozin on pancreatic beta cell mass in db/db mice of different ages K Takahashi, A Nakamura, H Miyoshi, H Nomoto, N Kitao, K Omori, ... Scientific reports 8 (1), 6864, 2018 | 28 | 2018 |
| Reduction in glucose fluctuations in elderly patients with type 2 diabetes using repaglinide: A randomized controlled trial of repaglinide vs sulfonylurea K Omori, H Nomoto, A Nakamura, T Takase, KY Cho, K Ono, N Manda, ... Journal of Diabetes Investigation 10 (2), 367-374, 2019 | 23 | 2019 |
| Nivolumab-induced hypophysitis causing secondary adrenal insufficiency after transient ACTH elevation T Sekizaki, H Kameda, C Oba, KY Cho, A Nakamura, H Miyoshi, T Osawa, ... Endocrine journal 66 (10), 937-941, 2019 | 20 | 2019 |
| Glucokinase Inactivation Paradoxically Ameliorates Glucose Intolerance by Increasing β-Cell Mass in db/db Mice K Omori, A Nakamura, H Miyoshi, Y Yamauchi, S Kawata, K Takahashi, ... Diabetes 70 (4), 917-931, 2021 | 19 | 2021 |
| Effect of switching from pioglitazone to the sodium glucose co‐transporter‐2 inhibitor dapagliflozin on body weight and metabolism‐related factors in patients with type 2 … KY Cho, A Nakamura, K Omori, T Takase, A Miya, N Manda, Y Kurihara, ... Diabetes, Obesity and Metabolism 21 (3), 710-714, 2019 | 19 | 2019 |
| Mitiglinide/voglibose fixed-dose combination improves postprandial glycemic excursions in Japanese patients with type 2 diabetes mellitus Y Ono, H Kameda, KY Cho Expert opinion on pharmacotherapy 14 (4), 361-370, 2013 | 19 | 2013 |
| Successful management of a patient with active Cushing’s disease complicated with coronavirus disease 2019 (COVID-19) pneumonia A Yuno, Y Kenmotsu, Y Takahashi, H Nomoto, H Kameda, KY Cho, ... Endocrine Journal 68 (4), 477-484, 2021 | 17 | 2021 |
| Impaired insulin secretion predicting unstable glycemic variability and time below range in type 2 diabetes patients regardless of glycated hemoglobin or diabetes treatment A Miya, A Nakamura, T Handa, H Nomoto, H Kameda, KY Cho, S Nagai, ... Journal of diabetes investigation 12 (5), 738-746, 2021 | 16 | 2021 |
| Evaluation of amnion-derived mesenchymal stem cells for treatment-resistant moderate Crohn’s disease: study protocol for a phase I/II, dual-centre, open-label, uncontrolled … S Otagiri, S Ohnishi, A Miura, H Hayashi, I Kumagai, YM Ito, T Katsurada, ... BMJ Open Gastroenterology 5 (1), e000206, 2018 | 16 | 2018 |
| The role of glucokinase and insulin receptor substrate-2 in the proliferation of pancreatic beta cells induced by short-term high-fat diet feeding in mice N Kitao, A Nakamura, H Miyoshi, H Nomoto, K Takahashi, K Omori, ... Metabolism 85, 48-58, 2018 | 15 | 2018 |
| Log-linear relationship between endogenous insulin secretion and glycemic variability in patients with type 2 diabetes on continuous glucose monitoring A Miya, A Nakamura, T Handa, H Nomoto, H Kameda, KY Cho, S Nagai, ... Scientific reports 11 (1), 9057, 2021 | 14 | 2021 |
